Patient Portal to Support Treatment Adherence
1 other identifier
interventional
304
1 country
2
Brief Summary
The purpose of this study is to conduct a randomized control trial of a behavioral intervention delivered by nurses via an electronic medical record (EMR) patient web portal to determine if this is an efficacious method for supporting medication adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2009
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 17, 2009
CompletedFirst Posted
Study publicly available on registry
June 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedOctober 13, 2017
October 1, 2017
3.3 years
June 17, 2009
October 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lapses in medication adherence over the last 7 and 30 days (self report) and over previous 12 months (pharmacy records).
12 months
Secondary Outcomes (1)
Web service utilization.
12 months
Study Arms (2)
staff emails
ACTIVE COMPARATORAttention control that includes staff sending emails with information about using health information technology system.
study nurse messages
EXPERIMENTALA series of 6 proactive secure messages and 3 proactive booster messages (for a total of 9 secure and personalized messages) sent by the study nurse via the EMR patient web portal.
Interventions
9 informational email messages sent by study staff about the features of the shared electronic medical record system and how to use them.
9 messages tailored by the study nurse and guided by the IMB model
Eligibility Criteria
You may qualify if:
- enrollment in GHC or KP health plans for at least 6 months
- expect to stay enrolled for 1 year in health plan
- HIV+
- currently prescribed antiretroviral medication
- regular access to a computer with internet capabilities and working email address and meet one of the following:
- gap in antiretroviral prescription refills based on 6 month refill records
- referral to study by provider team for adherence problems
You may not qualify if:
- dementia or psychosis diagnosis documented in medical record
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kaiser Permanente Northern California
Oakland, California, 94612, United States
Group Health Research Institute
Seattle, Washington, 98101, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Sheryl L. Catz, PhD
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2009
First Posted
June 18, 2009
Study Start
June 1, 2009
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
October 13, 2017
Record last verified: 2017-10